IQVIA™ Real-World Insights Bibliography

A COST-EFFECTIVENESS ANALYSIS COMPARING THE ORIGINATOR RECOMBINANT HUMAN ALFA TO THEIR BIOSIMILARS FOLLITROPIN ALFA FOR THE TREATMENT OF INFERTILITY.
Author(s): Ravonimbola H(1), Petrica N (1), Maurel F(1), Murphy C(2), Doré C(2), Fresneau L(2),
Affiliations(s): (1) QuintilesIMS, Paris France (2) Merck Serono, France
Publication(s):  ISPOR 2017
Document Type(s): Poster,
Countries: France,
Click here for the abstract
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2017
  L:
A:
English
Cost effectiveness, Literature Review, Randomised controlled trial,
  Add to report
 
 
HEALTH-ECONOMICS EVALUATIONS IN FRANCE, ENGLAND, CANADA AND AUTRALIA: COMPARISON OF METHODOLOGIES AND IMPACT ON DRUGS
Author(s): Bucher D*, Abalan M-E*, Allou A*, Dumon L*, Vialard L *, Troubat A*, Maurel F*
Affiliations(s): IQVIA France - RWI
Publication(s):  ISPOR 2017
Document Type(s): Poster,
Countries: Australia, Canada, France, UK,
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2017
  L:
A:
English
Cost effectiveness, Literature Review, Pricing & Reimbursement, Review,
  Add to report
 
 
RiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma.
Author(s): Coleman AL1,2, Lum FC1, Velentgas P3, Campion D3, Su Z3, Gliklich RE4; RiGOR Study Group.
Affiliations(s): 1H. Dunbar Hoskins Jr, MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA. 2Jules Stein Eye Institute, David Geffen School of Medicine & Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA. 3Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, Cambridge, MA 02139, USA.
Publication(s):  Journal of Comparative Effectiveness. Jan 2016; 5(1), 65-78
Document Type(s): Article,
Countries: 
Click here for the abstract
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2016
  L:
A:
English
Observational study, Prospective study, RWLPR (Real-World Late Phase Research-quintiles,
  Add to report
 
 
Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study
Author(s): Coleman AL1,2, Lum FC2, Velentgas P3, Su Z3, Gliklich RE4; RiGOR Study Group.
Affiliations(s): 1Jules Stein Eye Institute, David Geffen School of Medicine & Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA. 2H Dunbar Hoskins, Jr MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA. 3Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, Cambridge, MA 02139, USA. 4Massachusetts Eye & Ear & Harvard Medical School, Boston, MA 02114, USA.
Publication(s):  J Comp Eff Res. 2016 Jan;5(1):87-98
Document Type(s): Article,
Countries: 
Click here for the abstract
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2016
  L:
A:
English
Observational study, Prospective study,
  Add to report
 
 
Quality of life and visual acuity outcomes in the RiGOR study
Author(s): Coleman AL1,2, Lum FC1, Gliklich RE3, Velentgas P4, Su Z4; RiGOR Study Group.
Affiliations(s): 1H Dunbar Hoskins, Jr MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA. 2Jules Stein Eye Institute, David Geffen School of Medicine & Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA. 3Massachusetts Eye & Ear Infirmary & Harvard Medical School, Boston, MA 02114, USA. 4Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, 201 Broadway #5, Cambridge, MA 02139, USA.
Publication(s):  J Comp Eff Res. 2016 Jan;5(1):99-111.
Document Type(s): Article,
Countries: 
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2016
  L:
A:
English
Observational study, Prospective study,
  Add to report
 
 
Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study.
Author(s): Coleman AL1,2, Lum FC2, Velentgas P3, Su Z3, Gliklich RE4; RiGOR Study Group.
Affiliations(s): 1Jules Stein Eye Institute, David Geffen School of Medicine & Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA. 2H Dunbar Hoskins Jr, MD Center for Quality Eye Care, Foundation of the American Academy of Ophthalmology, 655 Beach Street, San Francisco, CA 94109, USA. 3Outcome DEcIDE Center, Quintiles Real World & Late Phase Research, Cambridge, MA, 02139. 4Massachusetts Eye & Ear Infirmary & Harvard Medical School, Boston, MA 02114, USA
Publication(s):  J Comp Eff Res. 2016 Jan;5(1):79-85.
Document Type(s): Article,
Countries: 
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2016
  L:
A:
English
Observational study, Prospective study,
  Add to report
 
 
How market access will play out
Author(s): Bosco j, Dreyer N
Affiliations(s): Quintiles Real World and late phase research
Publication(s):  Managed healthcare executive
Document Type(s): 
Countries: 
Click here for the abstract
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2016
  L:
A:
English
RWLPR (Real-World Late Phase Research-quintiles,
  Add to report
 
 
Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis.
Author(s): Mack CD1, Brookhart MA, Glynn RJ, Meyer AM, Carpenter WR, Sandler RS, Stürmer T.
Affiliations(s): Department of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
Publication(s):  Epidemiology. 2015 Sep;26(5):690-9.
Document Type(s): Article,
Countries: USA,
C:
Y:
Comparative Effectiveness & Health Technology Assessment, Oncology,
2015
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Best Methods to Get Your Comparative Effectiveness Paper Cited: How GRACE Helps.
Author(s): Dreyer NA, Bryant A, Velentgas P, Su Z.
Affiliations(s): Quintales real world and late phase research
Publication(s):  Pharmacoepidemiol Drug Saf 2015; 24(S1):360
Document Type(s): Abstract,
Countries: 
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2015
  L:
A:
English
Review, RWLPR (Real-World Late Phase Research-quintiles,
  Add to report
 
 
Generating Real-world Safety and Effectiveness Evidence for Biosimilars: Current Issues and Methodological Considerations
Author(s): Bosco JL, Dreyer NA, Neyarapally G, Brown JS.
Affiliations(s): Quintiles real world and late phase research
Publication(s):  Pharmacoepidemiol Drug Saf 2015; 24(S1):416.
Document Type(s): Abstract,
Countries: 
C:
Y:
Comparative Effectiveness & Health Technology Assessment,
2015
  L:
A:
English
Methodology, Review, RWLPR (Real-World Late Phase Research-quintiles,
  Add to report
 
 
First Page Previous Page  2 of 5 Next Page Last Page